A Multi-Institutional Phase II Trial of Bevacizumab for Recurrent and Refractory Meningioma
Neuro-oncology advances（2022）
Key words
anti-angiogenic,bevacizumab,dural tumors,hemangiopericytoma,high-grade meningioma,meningioma,solitary fibrous tumor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined